A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
COVID-19 vaccination guidelines for patients with multiple sclerosis
2021
Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Preserved Fulltext
The opinion of Russian experts on the possibility of COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number of domestic and foreign guidelines, conclude that it is possible to use killed and inactivated vaccines. Preliminary recommendations are given for COVID-19 vaccination, taking into account the MS disease modifying therapies.
doi:10.14412/2074-2711-2021-2-157-161
doaj:160bfabe4e594d8393af8e0708c38546
fatcat:qsaxdarryjgeneeyrz3gxl6nmu